7 mayo 2020 año - RCT (Preprint) - HCQ in patients with
mild to moderate COVID–19
Descripción:
"The results of our trial did not show additional benefits of virus elimination by adding HCQ to the current SOC in patients mainly with persistent mild to moderate COVID–19." [26]
Añadido al timeline:
fecha:
7 mayo 2020 año
Ahora mismo
~ 5 years ago